Basic Study on Boron Neutron Capture Therapy of Tumors Using Research Reactors

美国俄亥俄州立大学和京都大学反应堆研究所关于第一阶段(1988-1990财政年度)硼中子俘获疗法的联合研究反应堆已经完成。共有11名研究人员，其中6名日本人，5名美国人，通过研讨会、讨论会等交流信息。硼中子俘获疗法(BNCT)是一种利用核研究反应堆中的中子选择性治疗肿瘤的新临床方法。京都大学反应堆研究所(Kurri)在开发用于生物医学的中子场方面具有优势，而俄亥俄州立大学(OSU)在开发硼化合物方面具有优势。这两个研究领域对BNCT都是必不可少的。这个联合研究项目是基于一种非常典型的互让关系。通过3年的项目，库里和OSU都获得了巨大的利益。例如，俄亥俄州立大学的物理小组和库里的化学小组的研究活动极大地刺激了学生的学习。在这一计划期间，双方发表了许多论文。库里和俄亥俄州立大学都有继续这一联合研究计划的强烈意愿。

The Joint Research Reactor between the Ohio State University in U. S. A. and Kyoto University Research Reactor Institute on Boron Neutron Capture Therapy of the first stage (Fiscal 1988-1990) has been completed. Total 11 researchers, 6 Japanese and 5 Americans, were exchanged for information exchange through seminars, discussions and so on.Boron neutron capture therapy (BNCT) is a new clinical method to treat tumors selectively by using neutrons from a nuclear research reactor. Kyoto University Research Reactor Institute (KURRI) has an advantage in developing neutron fields for biomedicine.On the other hand the Ohio State University (OSU) has that in boron compound. Both research fields are essential for BNCT. This joint research program is based on a very typical give-and-take relation.Through the 3 year program, both KURRI and OSU have been obtained big benefits mutually. For example, research activities of physics group in OSU and chemistry group in KURRI have stimulated very much. Many paper have been published from both sides during this program.Both KURRI and OSU have a strong intention of the continuation of this joint research program.